Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Eisai Co., Ltd.
Systemic Lupus Erythematosus
China, Japan, South Korea, Taiwan
Sponsor: Pfizer
Pulmonary Arterial Hypertension
United States, Australia, Belgium, China, Czechia +7 more
Sponsor: Eli Lilly and Company
Nausea · Vomiting · Drug-Related Side Effects and Adverse Reactions · Neoplasms
United States, Australia, China, France, Italy +5 more
Sponsor: Institute for Clinical Effectiveness, Japan
Idiopathic Normal Pressure Hydrocephalus (INPH)
Japan
Sponsor: Eli Lilly and Company
Obesity · Overweight
United States, Argentina, Australia, Belgium, Brazil +10 more
Sponsor: argenx
Myasthenia Gravis · MG · gMG · Generalized Myasthenia Gravis
United States, Belgium, Germany, Greece, Italy +3 more
Sponsor: AstraZeneca
Prostate Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: Astellas Pharma Global Development, Inc.
Prostate Cancer · Metastatic Castration-Resistant Prostate Cancer · Metastatic Hormone Sensitive Prostate Cancer
United States, China, France, Germany, Italy +7 more
Sponsor: Kansai Medical University
Esophageal Cancer · Gastric Cancer (Diagnosis) · Upper Gastrointestinal Cancer
Japan
Sponsor: argenx
Graves Disease
Canada, Georgia, Japan
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +33 more
- An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusEnrolling By Invitation
Sponsor: Biogen
Systemic Lupus Erythematosus (SLE)
United States, Argentina, Belgium, Brazil, Bulgaria +23 more
Sponsor: Daiichi Sankyo
Advanced Solid Tumor
United States, Canada, France, Japan, Spain
Sponsor: Boehringer Ingelheim
Advanced Relapsed or Refractory Germ Cell Tumours · Advanced Relapsed or Refractory Endometrial Cancer · Advanced Relapsed or Refractory Ovarian Cancer
United States, Belgium, France, Germany, Japan +1 more
Sponsor: Eli Lilly and Company
Alcohol Use Disorder
United States, Belgium, China, Germany, Japan +3 more
Sponsor: Boehringer Ingelheim
Metabolic Dysfunction Associated Steatohepatitis (MASH) · Liver Fibrosis
United States, Argentina, Australia, Austria, Belgium +31 more
Sponsor: Amgen
Prostate Cancer
United States, Australia, China, Germany, Japan +5 more
- A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory NeuroblastomaActive Not Recruiting
Sponsor: Eli Lilly and Company
Neuroblastoma
United States, Australia, Belgium, France, Germany +4 more
Sponsor: Boehringer Ingelheim
Heart Failure
United States, Argentina, Australia, Belgium, Brazil +25 more
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +24 more
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Ovarian Neoplasms · Ovarian Cancer
United States, Argentina, Australia, Austria, Belgium +24 more
Sponsor: Eli Lilly and Company
Cognition Disorders
United States, Australia, Canada, Japan
Sponsor: Eli Lilly and Company
Carcinoma, Transitional Cell · Urinary Bladder Neoplasms · Neoplasm Metastasis
United States, Australia, Brazil, Canada, China +14 more
- Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Uterine Neoplasms · Uterine Cervical Neoplasms · Biliary Tract Neoplasms · Urologic Neoplasms
United States, Belgium, Germany, Italy, Japan +3 more
Sponsor: Merck Sharp & Dohme LLC
Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +26 more